Arthritis News

Anakinra (Kineret) is Safe and Well Tolerated in RA Patients with Comorbid Conditions from Johns Hopkins Arthritis

[…]

Infliximab (Remicade) Approved in Europe for Treatment of Ankylosing Spondylitis

Infliximab (Remicade®) is now approved in Europe for the treatment of ankylosing spondylitis (AS) patients who have severe axial symptoms, elevated serological markers of inflammatory activity and who have had an inadequate response to conventional therapy.

Predictors and Frequency of Infection in RA Patients

[…]

Adalimumab (Humira) Receives FDA Approval

[…]

Cytokine Traps: Novel Anti-Cytokine Blockers

[…]

Adalimumab (Humira) is Safe and Effective When Administered Concomitantly with Standard Anti-Rheumatic Therapy for the Treatment of Rheumatoid Arthritis (RA)

[…]

All in the Family: Two sisters’ experience with Rheumatoid Arthritis

“You have RA!”Padma: Growing up in Bombay, India in the sixties, my sister Rama and I definitely had our share of daily physical activity.

Exercise Tips for Arthritis Patients

How Does Exercise Affect my Joints? How Frequently Should I Be Exercising? Should I Lose Weight for Exercise to be

Risks and Benefits of Biologic Medications

Victoria Ruffing, RN, BC, Director of Patient Education at the Johns Hopkins Arthritis Center, shares the risks and benefits of biologic for

How to Manage Rheumatoid Arthritis Flares

Through research, doctors have a clearer understanding of how flares can impact a patient on a personal and emotional level. Dr. Uzma Haque

Complementary & Alternative Medicines for Psoriatic Arthritis

There are many complementary & alternative medicines and practices that have been found to be beneficial in curbing arthritis pain,

Arthritis News

Footer

Johns Hopkins Rheumatology

Connect With Us